Strain Information | |
---|---|
Image | |
BRC No. | RBRC10360 |
Type | Targeted Mutation![]() |
Species | Mus musculus |
Strain name | C57BL/6-Il22ra2<tm1.1Ksat> |
Former Common name | Il22ra2-/- mice |
H-2 Haplotype | |
ES Cell line | |
Background strain | C57BL/6JJcl |
Appearance | |
Strain development | Developed by Katsuaki Sato, Miyazaki University in 2018. JN/2 ES cells derived from B6 were used, and then mice were backcrossed to C57BL/6J over 12 generations. C57BL/6 congenic strain. Stop cassette was knocked in at Exon 1 of the Il22ra2 gene. |
Strain description | Il22ra2(interleukin 22 receptor, alpha 2) knockout mice. |
Colony maintenance | |
References | Pivotal Role of IL-22 Binding Protein in the Epithelial Autoregulation of Interleukin-22 Signaling in the Control of Skin Inflammation. Fukaya T, Fukui T, Uto T, Takagi H, Nasu J, Miyanaga N, Arimura K, Nakamura T, Koseki H, Choijookhuu N, Hishikawa Y, Sato K Front. Immunol., 9, 1418 (2018). 29977242 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
EGFP | Enhanced Green Fluorescent Protein (Aequorea victoria) | 10 | EGFP | ||||
HBEGF | heparin-binding EGF-like growth factor (human) | 10 | HBEGF | ||||
Il22ra2 MGI:2665114 | interleukin 22 receptor, alpha 2 | 10 | Il22ra2<tm1.1Ksat> | targeted mutation 1.1, Katsuaki Sato | |||
loxP | phage P1 loxP | 10 | loxP | ||||
herpes simplex virus thymidine kinase (HSV TK) polyA | 10 |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | STOP cassette (human HBEGF cDNA, jellyfish EGFP cDNA, herpes simplex virus thymidine kinase (HSV TK) poly A), Phage P1 loxP site, mouse Il22ra2 genomic DNA |
Research application | Cre/loxP system Fluorescent Proteins/lacZ System |
Specific Term and Conditions | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Front. Immunol., 9, 1418 (2018). Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEVELOPER (Dr. Katsuaki Sato) using the Approval Form. The Recipient acknowledges that RIKEN (and/or its original provider) reserves title to the Material. The Recipient will not transfer the Material to any scientists. The Recipient will not publish or present Research result without obtaining prior permission from the DEVELOPER (Dr. Katsuaki Sato). The Recipient will send Dr. Katsuaki Sato any abstract of submission, oral or written presentation, and/or copy of draft of paper or research article which is resulted from the Research at least 30 days prior to the submission. The RECIPIENT agrees to use this BIOLOGICAL RESOURCE as a collaboration with the DEVELOPER (Dr. Katsuaki Sato). |
Depositor | Katsuaki Sato (RIKEN) |
Strain Status | ![]() ![]() |
Strain Availability | Recovered litters from cryopreserved sperm (2 to 4 months) Cryopreserved sperm (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |